Skip to content
Clivatuzumab tetraxetan
Clivatuzumab tetraxetan is an antibody pharmaceutical. It is currently being investigated in clinical studies. It is known to target mucin-1.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
4 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pancreatic neoplasmsD010190EFO_0003860C25321——4
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameCLIVATUZUMAB TETRAXETAN
INNclivatuzumab tetraxetan
Description
Clivatuzumab tetraxetan (humanized mab)
Classification
Antibody
Drug classmonoclonal antibodies; chelating agents
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID943976-23-6
RxCUI—
ChEMBL IDCHEMBL3301586
ChEBI ID—
PubChem CID—
DrugBankDB15368
UNII ID1D1F7UG35J (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
MUC1
MUC1
Organism
Homo sapiens
Gene name
MUC1
Gene synonyms
PUM
NCBI Gene ID
4582
Protein name
mucin-1
Protein synonyms
Breast carcinoma-associated antigen DF3, CA 15-3, Cancer antigen 15-3, Carcinoma-associated mucin, CD227, EMA, Episialin, H23 antigen, H23AG, KL-6, Krebs von den Lungen-6, mucin 1, transmembrane, Peanut-reactive urinary mucin, PEM, PEMT, Polymorphic epithelial mucin, PUM, tumor associated epithelial mucin, Tumor-associated epithelial membrane antigen, Tumor-associated mucin
Uniprot ID
P15941
Mouse ortholog
Muc1 (17829)
mucin-1 (Q02496)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 33 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
5 adverse events reported
View more details